CartiHeal: Positive Study Results for Agili-C Implant
CartiHeal announced a study demonstrating that its Agili-C implant promotes the regenerative capacity of articular cartilage defects in a human cadaveric...
Nov 07, 2018,
Orthobiologics
ORTHOFLASHBone Therapeutics to End Phase III PREOB Study
The Data and Safety Monitoring Board recommended discontinuation of the Phase III hip osteonecrosis study of Bone Therapeutics' PREOB viscosupplement,...
Nov 06, 2018, Julie A. Vetalice
CartiHeal Reaches 100th Surgery in Agili-C IDE Study
CartiHeal has successfully enrolled and treated the 100th patient in the pivotal IDE study of the Agili-C implant. ...
Oct 26, 2018, Julie A. Vetalice
BONESUPPORT Begins Direct U.S. Sales of CERAMENT Bone Void Filler
BONESUPPORT commenced direct U.S. sales of bone void filler CERAMENT® BVF. ...
Oct 23, 2018, Julie A. Vetalice
Regentis Biomaterials Expands SAGE Trial of GelrinC
Regentis Biomaterials expanded the SAGE clinical trial of GelrinC to 11 U.S. sites. The investigational device is in evaluation to regrow knee...
Oct 23, 2018, Julie A. Vetalice
Kuros Biosciences Granted US Patent for Producing Osteoinductive Materials
Kuros Biosciences obtained U.S. Patent No. 10,064,892, "Method for producing an osteoinductive calcium phosphate and products thus obtained"....
Oct 22, 2018, Julie A. Vetalice
Bone Therapeutics Reports Results of Viscosupplement Study
Bone Therapeutics' first efficacy study of the JTA-004 viscosupplement to treat knee OA showed that a single injection delivered higher...
Oct 17, 2018, Julie A. Vetalice
Bone Solutions Completes 250 Cases with OsteoCrete Bone Void Filler
Bone Solutions announced completion of the first 250 cases of implanted OsteoCrete® magnesium-based bone void filler....
Oct 02, 2018, Julie A. Vetalice
Kuros Biosciences: First Procedure in MagnetOS Spinal Fusion Trial
The first patient has been treated in a multicenter study comparing Kuros Bioscience's MagnetOs bone graft substitute vs. autologous bone in...
Sep 28, 2018, Julie A. Vetalice
Baxter Receives FDA Clearance for ALTAPORE Bone Graft
Baxter was granted FDA 510(k) clearance to market ALTAPORE Bioactive Bone Graft as an autograft extender in posterolateral spinal fusion....
Sep 27, 2018, Julie A. Vetalice
Loading new posts...
No more posts
